Title : Newly developed reversible MAO-B inhibitor circumvents the shortcomings of irreversible inhibitors in Alzheimer's disease - Park_2019_Sci.Adv_5_eaav0316 |
Author(s) :
Park JH , Ju YH , Choi JW , Song HJ , Jang BK , Woo J , Chun H , Kim HJ , Shin SJ , Yarishkin O , Jo S , Park M , Yeon SK , Kim S , Kim J , Nam MH , Londhe AM , Cho SJ , Cho S , Lee C , Hwang SY , Kim SW , Oh SJ , Cho J , Pae AN , Lee CJ , Park KD |
Ref :
Sci Adv , 5 :eaav0316 , 2019 |
Abstract : Park_2019_Sci.Adv_5_eaav0316 |
ESTHER : Park_2019_Sci.Adv_5_eaav0316 |
PubMedSearch : Park_2019_Sci.Adv_5_eaav0316 |
PubMedID: 30906861 |